Research & Development

Alexion’s research and development programmes are focused on highly innovative therapies with the potential to transform the lives of patients with severe and life-threatening rare disorders for which there are no effective treatment options. Our scientists and researchers focus exclusively on these underserved patient populations, and work closely with the medical community to understand the underlying causes of these devastating diseases, so that we can identify and investigate potential breakthrough therapies to treat them.

Currently, Alexion’s research and development efforts are focused primarily in the areas of kidney transplant, neurology and metabolic disorders.

Click here to learn more about our pipeline.